Vanguard Group’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-910,775
| Closed | -$15.2M | – | 4098 |
|
|
2017
Q3 | $15.2M | Sell |
910,775
-106,205
| -10% | -$1.73M | ﹤0.01% | 2608 |
|
|
2017
Q2 | $18.2M | Sell |
1,016,980
-27,337
| -3% | -$511K | ﹤0.01% | 2497 |
|
|
2017
Q1 | $20.9M | Buy |
1,044,317
+95,369
| +10% | +$2.22M | ﹤0.01% | 2424 |
|
|
2016
Q4 | $23.8M | Buy |
948,948
+109,434
| +13% | +$2.59M | ﹤0.01% | 2351 |
|
|
2016
Q3 | $19.6M | Buy |
839,514
+53,102
| +7% | +$1.25M | ﹤0.01% | 2369 |
|
|
2016
Q2 | $15.7M | Sell |
786,412
-62,093
| -7% | -$1.16M | ﹤0.01% | 2436 |
|
|
2016
Q1 | $14.4M | Buy |
848,505
+45,025
| +6% | +$923K | ﹤0.01% | 2430 |
|
|
2015
Q4 | $17.8M | Buy |
803,480
+118,392
| +17% | +$2.46M | ﹤0.01% | 2349 |
|
|
2015
Q3 | $11.6M | Buy |
685,088
+24,747
| +4% | +$385K | ﹤0.01% | 2529 |
|
|
2015
Q2 | $9.08M | Buy |
660,341
+10,895
| +2% | +$145K | ﹤0.01% | 2730 |
|
|
2015
Q1 | $8.89M | Buy |
649,446
+43,166
| +7% | +$498K | ﹤0.01% | 2699 |
|
|
2014
Q4 | $6.41M | Sell |
606,280
-36,422
| -6% | -$431K | ﹤0.01% | 2766 |
|
|
2014
Q3 | $8.03M | Buy |
642,702
+11,769
| +2% | +$164K | ﹤0.01% | 2596 |
|
|
2014
Q2 | $8.63M | Buy |
630,933
+33
| +0% | +$431 | ﹤0.01% | 2568 |
|
|
2014
Q1 | $7.62M | Buy |
630,900
+123,157
| +24% | +$1.41M | ﹤0.01% | 2615 |
|
|
2013
Q4 | $6.24M | Buy |
507,743
+24,095
| +5% | +$283K | ﹤0.01% | 2674 |
|
|
2013
Q3 | $4.92M | Buy |
483,648
+7,527
| +2% | +$70.4K | ﹤0.01% | 2749 |
|
|
2013
Q2 | $4.28M | Buy |
+476,121
| New | +$4.8M | ﹤0.01% | 2753 |
|
Vanguard Group's OME Position: Q4 2017 in Review
Vanguard Group sold out of Omega Protein (OME) in Q4 2017, closing a stake of 910,775 shares — an estimated $15.2M sold.
Vanguard Group first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $23.8M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Vanguard Group reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Vanguard Group sold 910,775 Omega Protein shares in Q4 2017, an estimated $15.2M.
- Vanguard Group first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Vanguard Group's Omega Protein position peaked at $23.8M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.